Epstein–Barr Virus and Multiple Sclerosis: Mechanistic Insights into Virus-Driven Autoimmunity
Open Access
- 27 July 2026
- journal article
- review article
- Published by MDPI AG in Microorganisms
- Vol. 14 (8) , 1639
Abstract
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system characterized by immune-mediated demyelination and neurodegeneration. Although the exact cause of MS remains unclear, accumulating epidemiological and immunological evidence strongly implicates Epstein–Barr virus (EBV) infection as a major environmental factor associated with disease development. Nearly all individuals with MS are EBV seropositive, and longitudinal studies have demonstrated that EBV infection precedes MS onset, supporting a causal relationship. EBV establishes lifelong latency in B cells and can profoundly influence host immune responses, providing several potential mechanisms through which it may contribute to autoimmunity. In this review, we summarize current knowledge of EBV biology and discuss epidemiological findings linking EBV infection with MS risk. We then examine alterations in EBV-specific immune responses observed in MS, including dysregulated humoral and cellular immunity. Particular attention is given to molecular mimicry involving the Epstein–Barr nuclear antigen 1 (EBNA1) and central nervous system proteins, which may promote cross-reactive autoimmune responses. Finally, we discuss evidence for the presence and potential role of EBV-infected immune cells within the MS brain and highlight key unanswered questions that remain critical for understanding EBV-driven neuroinflammation.Keywords
This publication has 121 references indexed in Scilit:
- Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple SclerosisJAMA Neurology, 2024
- Epstein–Barr virus and multiple sclerosis: moving from questions of association to questions of mechanismClinical & Translational Immunology, 2023
- Association of Infectious Mononucleosis in Childhood and Adolescence With Risk for a Subsequent Multiple Sclerosis Diagnosis Among SiblingsJAMA Network Open, 2021
- Primary infection with the Epstein‐Barr virus and risk of multiple sclerosisAnnals of Neurology, 2010
- Elevated Epstein–Barr virus‐encoded nuclear antigen‐1 immune responses predict conversion to multiple sclerosisAnnals of Neurology, 2009
- Multiple Sclerosis After Infectious MononucleosisArchives of Neurology, 2007
- Epstein-Barr Virus and Multiple SclerosisArchives of Neurology, 2006
- Infectious mononucleosis and risk for multiple sclerosis: A meta‐analysisAnnals of Neurology, 2006
- Temporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple SclerosisJAMA, 2005
- Epstein-Barr Virus Antibodies and Risk of Multiple SclerosisJAMA, 2001